Henry Lik-yuen Chan

Henry Lik-yuen Chan

UNVERIFIED PROFILE

Are you Henry Lik-yuen Chan?   Register this Author

Register author
Henry Lik-yuen Chan

Henry Lik-yuen Chan

Publications by authors named "Henry Lik-yuen Chan"

Are you Henry Lik-yuen Chan?   Register this Author

100Publications

2701Reads

26Profile Views

Modelling the Economic and Clinical Burden of Non-Alcoholic Steatohepatitis in East Asia: Data from Hong Kong.

Hepatol Res 2020 Jun 14. Epub 2020 Jun 14.

Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.13535DOI Listing
June 2020

Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement.

Lancet Gastroenterol Hepatol 2020 Jun 22. Epub 2020 Jun 22.

Department of Medicine and Therapeutics, and Medical Data Analytic Centre, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(20)30190-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308747PMC
June 2020

Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B.

J Hepatol 2020 May 16;72(5):847-854. Epub 2019 Dec 16.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.12.005DOI Listing
May 2020

Reply to: "Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page".

J Hepatol 2020 May 15. Epub 2020 May 15.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2020.04.029DOI Listing
May 2020

Unresolved issues of immune tolerance in chronic hepatitis B.

J Gastroenterol 2020 Apr 3;55(4):383-389. Epub 2020 Feb 3.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00535-020-01665-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080668PMC
April 2020

Use of hepatitis B virus core-related antigen to evaluate natural history of chronic hepatitis B.

J Gastroenterol Hepatol 2020 Apr 15. Epub 2020 Apr 15.

Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Gifu, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.15058DOI Listing
April 2020

Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B.

J Gastroenterol Hepatol 2020 Feb 7. Epub 2020 Feb 7.

Faculty of Medicine, Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.15007DOI Listing
February 2020

Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposure.

J Hepatol 2020 Jan 6;72(1):57-66. Epub 2019 Sep 6.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.08.023DOI Listing
January 2020

Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China.

Gastroenterology 2020 01 28;158(1):215-225.e6. Epub 2019 Sep 28.

Institute of Digestive Disease, The Chinese University of Hong Kong; Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong; Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong; Hong Kong SAR, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2019.09.025DOI Listing
January 2020

Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis.

Aliment Pharmacol Ther 2019 11 16;50(9):1037-1048. Epub 2019 Sep 16.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15499DOI Listing
November 2019

Low Risk of Variceal Bleeding in Patients With Cirrhosis After Variceal Screening Stratified by Liver/Spleen Stiffness.

Hepatology 2019 09 15;70(3):971-981. Epub 2019 Mar 15.

Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hep.30522
Publisher Site
http://dx.doi.org/10.1002/hep.30522DOI Listing
September 2019

Performance of Simple Fibrosis Scores in Nonobese Patients With Nonalcoholic Fatty Liver Disease.

Clin Gastroenterol Hepatol 2019 Sep 28. Epub 2019 Sep 28.

Centre d'Investigation de la Fibrose Hépatique, Bordeaux University Hospital, Pessac, France; INSERM U1053, Bordeaux University, Bordeaux, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2019.09.027DOI Listing
September 2019

Growth arrest-specific gene 2 suppresses hepatocarcinogenesis by intervention of cell cycle and p53-dependent apoptosis.

World J Gastroenterol 2019 Aug;25(32):4715-4726

Department of Gastroenterology and Hepatology, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, Guangdong Province, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v25.i32.4715DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718038PMC
August 2019

Reply to: "NAFLD and beneficial effects of lifestyle intervention: Defining the meat of the matter".

J Hepatol 2019 06 2;70(6):1304. Epub 2019 Mar 2.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2019.02.008DOI Listing
June 2019

Improvement in enhanced liver fibrosis score and liver stiffness measurement reflects lower risk of hepatocellular carcinoma.

Aliment Pharmacol Ther 2019 06 25;49(12):1509-1517. Epub 2019 Apr 25.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15269DOI Listing
June 2019

Towards finite oral antiviral treatment for chronic hepatitis B.

Lancet Gastroenterol Hepatol 2019 04 20;4(4):260-262. Epub 2019 Feb 20.

Institute of Digestive Disease, Department of Medicine and Therapeutics, and State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(19)30045-7DOI Listing
April 2019

HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues.

J Hepatol 2019 03 25;70(3):361-370. Epub 2018 Oct 25.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.10.014DOI Listing
March 2019

Okuda lecture: Challenges of hepatitis B in the era of antiviral therapy.

J Gastroenterol Hepatol 2019 Mar 22;34(3):501-506. Epub 2018 Nov 22.

Department of Medicine and Therapeutics, Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/jgh.14534
Publisher Site
http://dx.doi.org/10.1111/jgh.14534DOI Listing
March 2019

Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis B.

Liver Int 2019 02 25;39(2):271-279. Epub 2018 Sep 25.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13953DOI Listing
February 2019

Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness.

J Gastroenterol Hepatol 2019 Jan 27;34(1):241-248. Epub 2018 Jun 27.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14311DOI Listing
January 2019

Gastrointestinal disease burden and mortality: A public hospital-based study from 2005 to 2014.

J Gastroenterol Hepatol 2019 Jan 30;34(1):124-131. Epub 2018 Jul 30.

Department of Medicine and Therapeutics, Institute of Digestive Disease, State Key Laboratory of Digestive Diseases, LKS Institute of Health Science, Chinese University of Hong Kong, Hong Kong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14377DOI Listing
January 2019

Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.

J Hepatol 2018 12 22;69(6):1349-1356. Epub 2018 Aug 22.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.08.011DOI Listing
December 2018

Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment.

Aliment Pharmacol Ther 2018 11 20;48(9):984-992. Epub 2018 Aug 20.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.14945DOI Listing
November 2018

Improvements in the management of chronic hepatitis B virus infection.

Expert Rev Gastroenterol Hepatol 2018 Nov 5;12(11):1153-1166. Epub 2018 Oct 5.

b Department of Medicine and Therapeutics and Institute of Digestive Disease , The Chinese University of Hong Kong , Hong Kong SAR , China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474124.2018.1530986DOI Listing
November 2018

On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis.

Am J Gastroenterol 2018 11 12;113(11):1629-1638. Epub 2018 Oct 12.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China. State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41395-018-0247-9DOI Listing
November 2018

Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B.

J Hepatol 2018 Oct;69(4):793-802

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.05.009DOI Listing
October 2018

Editorial: a baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients-same score, different outcomes. Author's Reply.

Aliment Pharmacol Ther 2018 10;48(8):876-877

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.14961DOI Listing
October 2018

Chronic Hepatitis B Increases Liver-Related Mortality of Patients With Acute Hepatitis E: A Territorywide Cohort Study From 2000 to 2016.

Clin Infect Dis 2018 09;67(8):1278-1284

Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciy234DOI Listing
September 2018

Effects of Diabetes and Glycemic Control on Risk of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen.

Clin Gastroenterol Hepatol 2018 05 12;16(5):765-773.e2. Epub 2017 Dec 12.

Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China; Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15423565173145
Publisher Site
http://dx.doi.org/10.1016/j.cgh.2017.12.009DOI Listing
May 2018

Impact of diabetes mellitus and hepatitis B virus coinfection on patients with chronic hepatitis C: A territory-wide cohort study.

J Gastroenterol Hepatol 2018 Apr 26;33(4):934-941. Epub 2018 Jan 26.

Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14003DOI Listing
April 2018

Prognostic Value of Controlled Attenuation Parameter by Transient Elastography.

Am J Gastroenterol 2017 Dec 31;112(12):1812-1823. Epub 2017 Oct 31.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong,China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2017.389DOI Listing
December 2017

Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.

J Hepatol 2017 11 24;67(5):902-908. Epub 2017 Jun 24.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.06.019DOI Listing
November 2017

Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes.

J Hepatol 2017 Oct 6. Epub 2017 Oct 6.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.09.020DOI Listing
October 2017

Durability of hepatitis B surface antigen seroclearance in untreated and nucleos(t)ide analogue-treated patients.

J Hepatol 2017 Oct 6. Epub 2017 Oct 6.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01688278173233
Publisher Site
http://dx.doi.org/10.1016/j.jhep.2017.09.018DOI Listing
October 2017

Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter.

J Hepatol 2017 09 12;67(3):577-584. Epub 2017 May 12.

Centre d'Investigation de la Fibrose Hépatique, Hôpital Haut-Lévêque, Bordeaux University Hospital, Pessac, France; INSERM U1053, Bordeaux University, Bordeaux, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.05.005DOI Listing
September 2017

Reply to: "Risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance".

J Hepatol 2017 Sep 19. Epub 2017 Sep 19.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.08.026DOI Listing
September 2017

Reply to: "Serum HBsAg kinetics in clinical prediction".

J Hepatol 2017 07 16;67(1):193-194. Epub 2017 Mar 16.

Department of Medicine and Therapeutics, Institute of Digestive Disease and State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.03.002DOI Listing
July 2017

Hepatitis B virus infection.

Best Pract Res Clin Gastroenterol 2017 06 9;31(3):237. Epub 2017 Jun 9.

IFI-Institute for Interdisciplinary Medicine, University of Hamburg, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2017.05.009DOI Listing
June 2017

The role of quantitative hepatitis B surface antigen revisited.

J Hepatol 2017 02 27;66(2):398-411. Epub 2016 Aug 27.

Department of Medicine and Therapeutics, Institute of Digestive Disease and State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2016.08.009DOI Listing
February 2017

Reply.

Hepatology 2016 11 17;64(5):1820-1821. Epub 2016 May 17.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28595DOI Listing
November 2016

Metabolic syndrome increases cardiovascular events but not hepatic events and death in patients with chronic hepatitis B.

Hepatology 2016 11 1;64(5):1507-1517. Epub 2016 Oct 1.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28778DOI Listing
November 2016

Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up.

Clin Gastroenterol Hepatol 2016 10 10;14(10):1481-1489.e5. Epub 2016 Feb 10.

Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, the Netherlands; Department of Public Health, Erasmus MC, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2016.01.019DOI Listing
October 2016

Pathogenesis and novel treatment options for non-alcoholic steatohepatitis.

Lancet Gastroenterol Hepatol 2016 09 10;1(1):56-67. Epub 2016 Aug 10.

Liver Research Group, Australian National University Medical School at The Canberra Hospital, Woden, ACT, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2468-1253(16)30011-5DOI Listing
September 2016

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.

Gut 2016 08 14;65(8):1359-68. Epub 2015 Apr 14.

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong State Key Laboratory in Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2015-309265DOI Listing
August 2016

Reply.

Hepatology 2016 08 18;64(2):685-6. Epub 2015 Dec 18.

Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28305DOI Listing
August 2016

Virus and Host Testing to Manage Chronic Hepatitis B.

Clin Infect Dis 2016 06;62 Suppl 4:S298-305

Department of Medicine and Therapeutics Institute of Digestive Disease State Key Laboratory of Digestive Disease, Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciw024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889896PMC
June 2016

Real-world risk score for hepatocellular carcinoma (RWS-HCC): a clinically practical risk predictor for HCC in chronic hepatitis B.

Gut 2016 May 19;65(5):887-8. Epub 2016 Jan 19.

Department of Gastroenterology & Hepatology, Singapore General Hospital, Singapore, Singapore Duke-NUS Medical School, Singapore, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2015-310818DOI Listing
May 2016

Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.

Clin Gastroenterol Hepatol 2016 Mar 18;14(3):461-468.e2. Epub 2015 Nov 18.

Genomics Research Center, Academia Sinica, Taipei, Taiwan; Graduate Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2015.10.033DOI Listing
March 2016

Chronic kidney disease: Treatment of hepatitis C virus infection in patients with CKD.

Nat Rev Nephrol 2016 Jan 23;12(1):5-6. Epub 2015 Nov 23.

Carol &Richard Yu PD Research Centre, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, 9/F Lui Che Woo Clinical Sciences Building, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneph.2015.189DOI Listing
January 2016

Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.

J Hepatol 2015 Nov 21;63(5):1190-7. Epub 2015 Jul 21.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2015.07.009DOI Listing
November 2015

Two are better than one: noninvasive assessment of liver fibrosis in nonalcoholic fatty liver disease.

Hepatol Int 2015 Oct 11;9(4):481-3. Epub 2015 Mar 11.

Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs12072-015-96
Web Search
http://link.springer.com/10.1007/s12072-015-9625-1
Publisher Site
http://dx.doi.org/10.1007/s12072-015-9625-1DOI Listing
October 2015

Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects.

Hepatology 2015 Sep 28;62(3):684-93. Epub 2015 Jul 28.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.27894DOI Listing
September 2015

Impact of IL28B and PNPLA3 polymorphisms on treatment outcomes in patients infected with genotype 6 hepatitis C virus.

J Gastroenterol Hepatol 2015 Jun;30(6):1040-8

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/jgh.12890
Publisher Site
http://dx.doi.org/10.1111/jgh.12890DOI Listing
June 2015

Adverse effects of vitamin D deficiency on outcomes of patients with chronic hepatitis B.

Clin Gastroenterol Hepatol 2015 Apr 28;13(4):783-90.e1. Epub 2014 Oct 28.

Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2014.09.050DOI Listing
April 2015

Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy.

J Hepatol 2015 Apr 13;62(4):956-67. Epub 2015 Jan 13.

1st Division of Gastroenterology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2015.01.002DOI Listing
April 2015

[The advances on the treatment of chronic hepatitis B: an update of 2014].

Zhonghua Gan Zang Bing Za Zhi 2015 Jan;23(1):2-4

View Article

Download full-text PDF

Source
January 2015